Cardlytics

Youtube Subscribe

Open: 8.04 Close: 7.64 Change: -0.4

The best way to get informed about Cardlytics without reading hundreds of pages.

The game is changing. There is a new strategy to evaluate Cardlytics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cardlytics are: SRS, Cardlytics, share, settlement, agreement, shareholder, CDLX, and the …

Concept Map

Semantic Network

Stock Summary

Scott Grimes is the co-founder and executive chairman of Atlanta-based Cardlytics. Grimes owns 249,279 shares worth more than $2,103,915 as of December 10th. Grimes has not been actively trading shares in.

Today's Summary

Several institutional investors and hedge funds have recently added their stakes in the business. COO Amit Gupta sold 72,658 shares of the company on January 24, 2024. Lake Street analyst Jacob Stephan reiterated a Buy rating on Cardlytics.

Today's News

Cardlytics shares rise 25% after resolving shareholder dispute - marketwatch.com. Several institutional investors and hedge funds have recently added their stakes in the business. Cardlytics, Inc. (NASDAQ: CDLX) expects to achieve positive adjusted EBITDA for the full year 2023. COO Amit Gupta sold 72,658 shares of the company on January 24, 2024. Lake Street analyst Jacob Stephan reiterated a Buy rating on Cardlytics ( CDLX – Research Report ) today and set a price target of $13.00. Currently, the analyst consensus on cardlytics is a Moderate Buy with an average price target. Cardlytics entered into a settlement agreement with SRS, the entity representing the former shareholders of Bridg. In connection with the settlement agreement, Cardlytic agreed to pay SRS $25 million in cash and issue SRS 3.6 million shares. Cardlytics entered into a settlement agreement with SRS, the entity representing the former shareholders of Bridg, on January 25, 2024. In connection with the settlement agreement, Cardlytic agreed to pay SRS $25 million in cash and issue SRS 3.6 million shares of cardlytics common stock.

Stock Profile

" Cardlytics offers extensive insight and marketing support for retailers, with access to spending data from over 20 million UK bank accounts. The 2023 holiday season is just around the corner, and this year consumers will be headed to their favorite online and in-store brands. Scott Grimes is the co-founder and executive chairman of Atlanta-based Cardlytics. Grimes owns 249,279 shares worth more than $2,103,915 as of December 10th. Grimes has not been actively trading shares in the past ninety days. Cardlytics, inc. (CDLX) stock price, quote, news & analysis. Scott Grimes holds the position of Executive Chairman at Cardlytic Inc. Scott Grimes owns over 6 units of Cardlytics Inc stock, valued at over $2,114,622. Grimes has made numerous trades, selling units worth over $38,207,909 in the past 7 years. Grimes executive role as the Chairman of the Board at Cardlytic Inc has provided him with significant compensation. Cardlytics leverages its extensive purchase intelligence to provide advertisers with valuable insights into consumer spending habits and preferences. Data-driven insights enable advertisers to deliver highly targeted and relevant offers to consumers based on their actual purchase behavior. Cardlytics works with financial institutions, including Bank of America, PNC, and Lloyds Banking Group, to analyze consumer spending data. Cardlytics cash cow products have demonstrated resilience and stability in the face of market fluctuations. In 2022, the company reported a net income of $15.7 million from their cash cow offerings. In 2023, the firm reported a gross profit of $98.3 million from these cash cow offers."

Keywords

This document will help you to evaluate Cardlytics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cardlytics are: SRS, Cardlytics, share, settlement, agreement, shareholder, CDLX, and the most common words in the summary are: cardlytics, stock, best, broker, invest, crypto, cdlx, . One of the sentences in the summary was: Several institutional investors and hedge funds have recently added their stakes in the business. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #cardlytics #stock #best #broker #invest #crypto #cdlx.

Read more →

Youtube Subscribe

---